Denton, TX, United States
Denton, TX, United States
SEARCH FILTERS
Time filter
Source Type

In 2015, the top five companies comprising AmerisourceBergen Corporation, DB Schenker, UPS, FedEx, and DHL held the dominant share of 31% in the global biopharmaceutical logistics market. Aiming at expanding their regional footprint, several of the established players are investing in construction of facilities across emerging nations. Also to make their foothold stronger, the leading market players are providing user-friendly shipping, e-commerce, logistics management, and visibility tools. Considering the strategies undertaken by the players in a dynamic business environment, experts predict positive outlook for the global biopharmaceutical logistics market. According to TMR, the global biopharmaceutical logistics market will reach US$120.7 bn, exhibiting a CAGR of 6.2% between 2016 and 2024. In 2015, the market was valued at US$70.9 bn. Based on type, the market can be bifurcated into cold chain logistics and non-cold chain logistics. Of these, the non-cold chain logistics segment held the leading share of 80% in the global market in 2015. Regionally, North America emerged dominant with a share of 32.9% in the global market in 2015. Sound Know-how of Logistics Providers to Create Growth Opportunities for Market Many logistics providers are making positive strides in the market and are seen enhancing their regional and local presence and expertise. These companies have sound knowledge and a strong network of local contacts. The sound know-hows of logistics providers can help in reducing challenges for pharmaceutical companies especially those running critical trials in emerging markets, or shipping in politically and legally difficult zones. This is also driving the expansion of the global biopharmaceutical logistics market. Cold chain carriers have considerably invested in devices built into refrigeration units to monitor location and temperature aimed at meeting industry demands. The technology has also enabled drug manufacturers to access relevant data in real time. It also offers increased visibility and the opportunity to prevent or mitigate loss of a critical shipment. The advent of the technology, coupled with recent innovations in packaging has provided significant impetus to the biopharmaceutical logistics market. Also with the increasing manufacture and usage biological drugs, the demand for biopharmaceutical logistics is expected to get spurred. Inquire for a sample copy of this Report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23858 On the downside, the cost of transporting biopharmaceuticals, especially the ones that are temperature sensitive and need rapid delivery to destinations, is very expensive. As with companies opting for air transport, they claim air shipping to cost considerably higher than transporting by sea. As fast shipping of highly temperature sensitive biopharmaceuticals is only possible by air transport, it has emerged as a major challenge for the market players. Also regulatory concerns and region-specific temperature control challenges are posing threat to the global biopharmaceutical logistics market. Advent of Targeted Therapies to Pave Way for Growth The world of medicine has witnessed a new wave of targeted therapies, which are designed as per the treatment needs of a particular patient. Therefore, the demand for targeted logistics solutions is expected to gain pace as therapies and drugs evolve to meet demands of more targeted approach. These developments are likely to help the market emerge out of the aforementioned challenges. Besides this, advent of innovative solutions aimed at mitigating challenges in clinical trial supply chain is likely to aid the market's expansion in the coming years. Information that this review is based on is derived from a TMR report, titled "Biopharmaceutical Logistics Market (Type - Cold Chain Logistics and Non-cold Chain Logistics; Mode of Transportation - Air Shipping, Sea Shipping, Road Shipping, and Rail Shipping; Service -Transportation and Warehousing) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024." The report segments the global biopharmaceutical logistics market as: Pharmerging Market (Product Type - Pharmaceuticals (Branded Prescription Drugs, Generic Drugs (Branded Generics, Unbranded Generics, and OTC Drugs) and Healthcare (Medical Devices, Diagnostic Instruments, and IT and Record Management); Economic Growth Levels - Tier - 1, Tier - 2, and Tier - 3; Indications - Lifestyle Diseases, Cancer and Autoimmune Diseases, and Infectious Diseases; Distribution Channel - Hospitals, Clinics, Retail Pharmacies, E-commerce, and Drug Stores) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024 Pharmacy Repackaging Systems Market (Product - Blister Card/Compliance Packaging Systems (Multi Dose Blister Card Packaging Systems, Single Dose Blister Card Packaging Systems, Heat Sealers, and Deblisters Machines), Pouch Packaging Automation Systems (Automatic Tablet Packager and Pouch Verification System), Bottle Filling/ Pill Counting Automation Systems (Automated Bottle Filler and Pill Counter), and Liquid Medication Packaging Systems (Oral Liquid Filling Syrup and Automated Vial Filling Pump) ; End User - Retail/Community Pharmacy, Hospital Pharmacy, Long-term Care (LTC) Pharmacies, and Mail Order Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024 Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.


In 2015, the top five companies comprising AmerisourceBergen Corporation, DB Schenker, UPS, FedEx, and DHL held the dominant share of 31% in the global biopharmaceutical logistics market. Aiming at expanding their regional footprint, several of the established players are investing in construction of facilities across emerging nations. Also to make their foothold stronger, the leading market players are providing user-friendly shipping, e-commerce, logistics management, and visibility tools. Considering the strategies undertaken by the players in a dynamic business environment, experts predict positive outlook for the global biopharmaceutical logistics market. According to TMR, the global biopharmaceutical logistics market will reach US$120.7 bn, exhibiting a CAGR of 6.2% between 2016 and 2024. In 2015, the market was valued at US$70.9 bn. Based on type, the market can be bifurcated into cold chain logistics and non-cold chain logistics. Of these, the non-cold chain logistics segment held the leading share of 80% in the global market in 2015. Regionally, North America emerged dominant with a share of 32.9% in the global market in 2015. Sound Know-how of Logistics Providers to Create Growth Opportunities for Market Many logistics providers are making positive strides in the market and are seen enhancing their regional and local presence and expertise. These companies have sound knowledge and a strong network of local contacts. The sound know-hows of logistics providers can help in reducing challenges for pharmaceutical companies especially those running critical trials in emerging markets, or shipping in politically and legally difficult zones. This is also driving the expansion of the global biopharmaceutical logistics market. Cold chain carriers have considerably invested in devices built into refrigeration units to monitor location and temperature aimed at meeting industry demands. The technology has also enabled drug manufacturers to access relevant data in real time. It also offers increased visibility and the opportunity to prevent or mitigate loss of a critical shipment. The advent of the technology, coupled with recent innovations in packaging has provided significant impetus to the biopharmaceutical logistics market. Also with the increasing manufacture and usage biological drugs, the demand for biopharmaceutical logistics is expected to get spurred. Inquire for a sample copy of this Report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23858 On the downside, the cost of transporting biopharmaceuticals, especially the ones that are temperature sensitive and need rapid delivery to destinations, is very expensive. As with companies opting for air transport, they claim air shipping to cost considerably higher than transporting by sea. As fast shipping of highly temperature sensitive biopharmaceuticals is only possible by air transport, it has emerged as a major challenge for the market players. Also regulatory concerns and region-specific temperature control challenges are posing threat to the global biopharmaceutical logistics market. Advent of Targeted Therapies to Pave Way for Growth The world of medicine has witnessed a new wave of targeted therapies, which are designed as per the treatment needs of a particular patient. Therefore, the demand for targeted logistics solutions is expected to gain pace as therapies and drugs evolve to meet demands of more targeted approach. These developments are likely to help the market emerge out of the aforementioned challenges. Besides this, advent of innovative solutions aimed at mitigating challenges in clinical trial supply chain is likely to aid the market's expansion in the coming years. Information that this review is based on is derived from a TMR report, titled "Biopharmaceutical Logistics Market (Type - Cold Chain Logistics and Non-cold Chain Logistics; Mode of Transportation - Air Shipping, Sea Shipping, Road Shipping, and Rail Shipping; Service -Transportation and Warehousing) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024." The report segments the global biopharmaceutical logistics market as: Pharmerging Market (Product Type - Pharmaceuticals (Branded Prescription Drugs, Generic Drugs (Branded Generics, Unbranded Generics, and OTC Drugs) and Healthcare (Medical Devices, Diagnostic Instruments, and IT and Record Management); Economic Growth Levels - Tier - 1, Tier - 2, and Tier - 3; Indications - Lifestyle Diseases, Cancer and Autoimmune Diseases, and Infectious Diseases; Distribution Channel - Hospitals, Clinics, Retail Pharmacies, E-commerce, and Drug Stores) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024 Pharmacy Repackaging Systems Market (Product - Blister Card/Compliance Packaging Systems (Multi Dose Blister Card Packaging Systems, Single Dose Blister Card Packaging Systems, Heat Sealers, and Deblisters Machines), Pouch Packaging Automation Systems (Automatic Tablet Packager and Pouch Verification System), Bottle Filling/ Pill Counting Automation Systems (Automated Bottle Filler and Pill Counter), and Liquid Medication Packaging Systems (Oral Liquid Filling Syrup and Automated Vial Filling Pump) ; End User - Retail/Community Pharmacy, Hospital Pharmacy, Long-term Care (LTC) Pharmacies, and Mail Order Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024 Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.


News Article | May 22, 2017
Site: www.prnewswire.com

The report and other materials are available for download at www.health2resources.com/comprehensive_medication_management.html. Through the effective and appropriate use of medications, CMM seeks to optimize patient outcomes by focusing on the patient and the goals of therapy. It encompasses all medications and all disease states, so pharmacists, through collaborative practice, can add, modify and change medications to resolve drug therapy problems for all conditions. "With medications representing 85 percent of the means by which we prevent and control disease, getting the medications right should be our number one priority—period," McInnis says.  "I am thrilled for my friends at Health2 Resources, who share this passion for better care and have the expertise and experience to manage and produce projects of such high quality and impact. " "This award speaks to the power of collaboration," says Katherine Herring Capps, president of Health2 Resources. "Working with Terry—a national expert on the topic--was a privilege. Of course, this work would have been impossible without support from the Community Pharmacy Foundation. "The work we're being honored for is only the beginning," she added. "The case examples in the report show how CMM can—and does—work, but broad adoption and payment reform are needed to change patients' lives." The Hermes Creative Awards is an international competition administered by the Association of Marketing and Communication Professionals. Other 2017 Gold winners include AARP and Mathematica Policy Research. Judges are industry professionals who look for companies and individuals whose talent exceeds a high standard of excellence and whose work serves as an industry benchmark. Health2 Resources also won a Hermes Gold for its development of a website for Colorado-based Monument Health (www.MonumentHealth.net). Additionally, this project earned a silver Aster Award for outstanding excellence in health care advertising, marketing and communications. About Health2 Resources  Founded in 1998, Health2 Resources is a full-service communications and public relations firm that exclusively serves health care clients throughout the U.S. by offering a full range of research and public relations support. It works closely with local, state and federal policymakers and regulatory agencies to build and improve relationships on behalf of a mix of clients that buy, pay for, provide and evaluate health care. Visit Health2 Resources at www.health2resources.com. 1 McInnis, T. Capps, K. Get the medications right: a nationwide snapshot of expert practices—Comprehensive medication management in ambulatory/community pharmacy. Health2 Resources, May 2016 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/health2-resources-wins-a-second-gold-from-2017-hermes-creative-awards-300461361.html


The Long Live Skin campaign will start by focusing on proper sun safety during May, which is Skin Cancer Awareness Month.  The campaign will continue throughout the summer and will include in-store signage with information and tips on sun protection and skincare, additional videos with skincare advice shared via social, digital and radio, as well as special weekly ExtraCare offers on skincare, sun care and more. "We are proud to launch the Long Live Skin campaign to educate and engage consumers around skincare, and this program is a natural extension of CVS Pharmacy's ongoing efforts to help customers on their path to better health," said Judy Sansone, Senior Vice President of Front Store Business & Chief Merchant at CVS Pharmacy. "Taking good care of your skin is part of taking care of your health, so we're making it easier than ever for our shoppers to access the information and products they need, including those with greater skin health benefits." In addition, CVS Pharmacy and Johnson & Johnson have partnered with the American Cancer Society to create exclusive content for in store signage, cvs.com and the CVS Pharmacy circular.  CVS Pharmacy Beauty Consultants will share the information and tips on the importance of proper sun care and skin health with customers.  Johnson & Johnson will donate $1 for every Neutrogena or Aveeno product with SPF 15 or higher purchased from June 18-24 to the American Cancer Society to help prevent skin cancer. "We applaud CVS Pharmacy for working on a campaign to educate and empower consumers to be more proactive regarding skin health," said Dr. Richard Wender, American Cancer Society Chief Cancer Control Officer.  "We are thrilled to participate in this partnership that focuses on skin cancer prevention and early detection—to help ensure a healthy and safe summer for everyone." The Long Live Skin campaign is also supported by other initiatives focused on healthy skincare and the importance of sun protection: To learn more, https://www.cvs.com/longliveskin.  To join the Long Live Skin conversation online, share your best skincare advice with #AdviceToMyYoungerSelf on your social channels. CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), is America's leading retail pharmacy with over 9,700 locations. It is the first national pharmacy to end the sale of tobacco and the first pharmacy in the nation to receive the Community Pharmacy accreditation from URAC, the leading health care accreditation organization that establishes quality standards for the health care industry. CVS Pharmacy is reinventing pharmacy to help people on their path to better health by providing the most accessible and personalized expertise, both in its stores and online at CVS.com. General information about CVS Pharmacy is available at http://www.cvshealth.com. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cvs-pharmacy-launches-long-live-skin-campaign-to-increase-awareness-around-sun-safety-and-skin-health-300457373.html


HONG KONG, May 18, 2017 /PRNewswire/ -- Hong Kong Lung Cancer Study Group (HKLCSG) today announces the results of the first survey that looks at how Hong Kong people think about the psychological challenges facing lung cancer patients. The survey, conducted online in April 2017 by an independent third-party research agency, polled 1,029 people in Hong Kong above the age of 18. Key findings include: "Lung cancer is one of the most common cancers globally and in Hong Kong, and the leading cause of cancer death in the city. The survey reveals that most Hongkongers don't think there is a treatment for late-stage lung cancer, and patients lose hope due to limited treatment options and treatment side effects," says Dr. Siu-Kie Au, Clinical Oncologist and President of HKLCSG. "As a matter of fact, medical advances are now offering more new treatment options with less side effects to late-stage lung cancer patients, especially for those with non-small cell lung cancer (NSCLC). Patients can now live longer and have a better quality of life." Most lung cancers are divided into two main types: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC is the most common lung cancer type, accounting for about 80-85% of lung cancers.1 Medical studies have discovered that the growth of some lung cancers depends on the presence of certain driver gene mutations in cancer, such as EGFR and ALK. EGFR mutation is the most common type of driver gene mutation in lung cancer present in the tumors of about 30-40% of Asian with late-stage NSCLC.2 Mutation testing plays an important role in helping identify the mutation and guide treatment options. When late-stage NSCLC progresses after first-line targeted therapy, the testing of EGFR T790M may help find out if the cancer has developed further mutation that causes resistance to the treatment and if a personalized treatment can be used to control the progression. Psychological well-being and raising public awareness help bring hope to patients in the fight against lung cancer Results of the survey show that most respondents believe patients face psychological challenges. "Negativity" is considered to affect patients the most. Dr. Angus Leung, Clinical Oncologist and member of HKLCSG, echoes the survey results and says, "Nowadays there are more treatment options available. However, patients go on an emotional rollercoaster through first-line treatment, improvement, progression, and second line treatment. Staying positive comes before any effective treatment.  As our survey results show, family, friends and caregivers can best support the patients by staying positive and embracing reality." Dr. Patricia Poon, Clinical Oncologist and council member of HKLCSG adds, "With my own patients, I have seen many of their families, friends and caregivers form a support group to partner with doctors to encourage patients, and help them spend more quality time with their loved ones." The survey results indicate that Hongkongers think the public should provide more emotional support to lung cancer patients and one way to help is to raise public awareness. Dr. Stephen Yau, Clinical Oncologist and member of HKLCSG says, "We are delighted to see that the public thinks society should offer more emotional support. HKLCSG is responding to that call to action by organising a series of activities to create a channel for the public to get involved. We look forward to seeing everyone there." "A Breath of Hope" Campaign brings hope to lung cancer patients and supports them "Living with Lung Cancer" For those living with lung cancer, each breath is a treasure and a celebration of life. HKLCSG is launching a large-scale educational campaign called "A Breath of Hope -- Living with Lung Cancer" this year to support lung cancer patients and help them fight against the disease. The campaign hosts an educational website (www.livingwithlungcancer.asia) that provides information and resources to help patients and the general public understand more about lung cancer. The campaign starts with a four-day exhibition - "Sending a Breath of Hope to Lung Cancer Patients" -- at iSQUARE at Tsim Sha Tsui on 18 -- 21 May. The public is invited to take photos at the creative photo booths and share them online, and send calligraphy postcards with good wishes to support lung cancer patients. For every photo taken and shared or every postcard sent, "A Breath of Hope" campaign organiser will donate HK$5 to St. James' Settlement to support cancer care. In the coming few months, "A Breath of Hope" will invite lung cancer patients and their family and caregivers to participate in various activities to support them along their journey of "Living with Lung Cancer". Potential activities include breathing exercises with a Qi Gong master, cooking for cancer patients, and physiotherapy to relieve pain. For more information, please visit the official website (www.livingwithlungcancer.asia). The Hong Kong Lung Cancer Study Group (HKLCSG) is a charitable institution established in 2003 by a group of oncology specialists. The objectives of the HKLCSG are to promote interest in the knowledge of lung cancer, to facilitate research for improving the knowledge and treatment of lung cancer, and to improve the standard of care for patients with lung cancer. About "A Breath of Hope -- Living with Lung Cancer" Campaign "A Breath of Hope -- Living with Lung Cancer" is a campaign supported by Hong Kong Lung Cancer Study Group (HKLCSG), aimed at raising public awareness of lung cancer and providing support to patients and their families and caregivers. The campaign logo features a dandelion to symbolise life through all challenges and difficulties and sending good wishes. "A Breath of Hope" hosts an educational website that provides information and resources about lung cancer. In the coming months, the campaign will run a series of events to support lung cancer patients and their families and caregivers. To find out more about the campaign and how you can help, please visit: www.livingwithlungcancer.asia. St. James' Settlement established in 1949, is a multi-social service agency. It provides high quality comprehensive services to meet the diverse needs of the society, to encourage individuals to help themselves and to help others, and hence to build an integrated and harmonious community. In 2009, The Philanthropic Community Pharmacy was established under St. James' Settlement. It is the first nonprofit community pharmacy in Hong Kong aimed at making self-financed items prescribed by hospitals and clinics under the Hospital Authority available at an affordable price to deprived patients. Apart from alleviating their financial burden for drug expenses, St James' Settlement provides holistic care to the patients, ranging from enhancing awareness towards proper medication usage, promoting public health education to comprehensive oncology support.


— Global Augmented Reality and Virtual Reality in Healthcare Market is expected to grow at a CAGR of 17.2% during the forecast period. Growing healthcare expenditure on emerging technologies and devices, rising private funds and greater emphasis on delivery of efficient healthcare services are the key factors driving the market growth. Lack of clear regulatory guidelines for their medical use is restraining the growth of augmented reality and virtual reality in healthcare market. North America is the leading market followed by Europe. Key factors contributing to the market growth in North America are the ease of access to technologies and well-established distribution channels. Emerging markets act as lucrative destinations for players involved in the market. Some of the key players in the market include Siemens Healthcare, CAE Healthcare, Layar B.V, Artificial Life, Inc., Philips Healthcare, Intuitive Surgical Inc., OnStar, LLC, Foursquare Labs, Inc., EON Reality, GE Healthcare, Hologic, Inc., Vuzix Corp, Vital Images, Inc., Simulab Corp, Medtronic, TheraSim, Inc., VirtaMed, Laerdal Medical, WorldViz, LLC, Immersion Corp, Oculus VR, LLC, Aruba Networks and Gowalla. Application Covered: • Fitness Management • Pharmacy benefit Management • Education • Diagnostics • Rehabilitation and Therapeutics • Medical Training • Pain Distraction • Surgical and Diagnostic Imaging • Patient Care Management • Virtual Reality Exposure Therapy (VRET) • Simulation • Other Applications End User Covered: • Advertising Agencies • Hospitals and Clinics • Research laboratories • Community Pharmacy • Pharmaceutical and Biotechnology Companies • Academic Institutes Unit • Government Agencies • Other End User What our report offers: – Market share assessments for the regional and country level segments – Market share analysis of the top industry players – Strategic recommendations for the new entrants – Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets – Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) – Strategic recommendations in key business segments based on the market estimations – Competitive landscaping mapping the key common trends – Company profiling with detailed strategies, financials, and recent developments – Supply chain trends mapping the latest technological advancements About Us Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. For more information, please visit https://www.wiseguyreports.com/sample-request/562752-augmented-reality-and-virtual-reality-in-healthcare-global-market-outlook-2015-2022


News Article | February 15, 2017
Site: www.prweb.com

Community Care of North Carolina (CCNC) is facilitating a collaboration of health information technology (HIT) and pharmacy management vendors that aims to enhance the role community-based pharmacists play in providing integrated clinical services to patients. The effort will use existing standards adopted by medical providers in electronic medical records to develop an electronic pharmacy “care plan” – a shared document detailing a patient’s comprehensive medication use, health challenges and social care needs. The pilot will deploy across North Carolina pharmacies that are participating in the Community Pharmacy Enhanced Services Network (CPESNSM), a project supported by CCNC and the National Community Pharmacists Association. The Office of National Coordinator for Health Information Technology (ONC), encourages improved care coordination between pharmacists and other health care providers through various initiatives, grants, policies and regulations. For this effort, CCNC is a community based partner supporting ONC’s High Impact Pilot Award Recipient Lantana Consulting Group in implementing use of the electronic care plan among community pharmacists. The CPESN network will provide targeted services to an eligible population of greater than 3 million Medicaid, Medicare, and dually-eligible recipients. The project combines the efforts of five pharmacy management systems: Computer-Rx, PioneerRx, QS/1, RX30, VIP Pharmacy Systems and Creative Pharmacist as a clinical pharmacy intervention platform. This will allow pharmacy staff to document records in their own native system to simplify and streamline their workload while also documenting their role in population health management. Pharmacists will use the systems to share care plans electronically and improve care coordination. CCNC will receive the care plans and use electronic health record-ready, standardized data to assess quality of care and manage payment for enhanced services offerings. The move to an interoperable care plan linking pharmacists with other clinicians will reduce redundant data entry, make care plans more consistent in structure, and allow clinical information emanating from community pharmacies to be more easily exchanged with other members of the care team. The payment for enhanced services offerings are part of a 3-year cooperative agreement funded by the Centers for Medicare and Medicaid Innovation (CMMI) to test new reimbursement models for community pharmacies serving Medicaid, Medicare, dually eligible, and NC Health Choice beneficiaries. The project requires that participants assess project impact in three areas: practice efficiency, clinical quality, and interoperability. Troy Trygstad, VP of Pharmacy Programs for CCNC, reports that “We are thrilled to help accelerate Community-Based Pharmacy care coordination efforts by integrating their activities with the rest of the care team. As an organization focused on providing wrap-around support for primary care, we see high demand for efficient and effective exchange of care plans and associated information between pharmacies, practices, and other care team members. CPESN networks will greatly aid in that effort.” Shelly Spiro, Executive Director, Pharmacy Heath Information Technology (PHIT) Collaborative is pleased to assist CCNC and the pharmacy management system vendors with implementation of the Pharmacist eCare Plan standard project. This project meets the PHIT Collaborative’s mission of advocating and educating key stakeholders regarding the meaningful use of heath IT and the inclusion of pharmacists within a technology-enabled integrated health care system. The members of the PHIT Collaborative including the nine largest national pharmacy professional associations together with many significant related Associate Members support this effort. Tricia Lee Wilkins, Pharmacy Advisor and Health IT Specialist for ONC, states that “Pharmacists provide crucial services and clinical interventions necessary for optimizing patient health outcomes. For decades, the profession of pharmacy has pioneered use of information technology for medication management systems. It is exciting to see innovative pharmacists use health IT to support not only the documentation of clinical care but the exchange of that information as well.” The CCNC and the pharmacy management vendors are receiving implementation support from Lantana Consulting Group, the developer of the exchange specification, under a high-impact pilot cooperative agreement from the Office of the National Coordinator for Health IT. “We believe strongly in the power of efficient data standards to inform and improve care. This work inserts pharmacists into the information exchange economy and we are very pleased to support them in this effort,” says Zabrina Gonzaga, RN, manager of clinical analysis and policy at Lantana. About CCNC CCNC is the smart choice for physicians, providers and payers looking for ways to reduce costs and financial risks associated with managing high-cost, complex patients. The CCNC enterprise includes 14 community-based care management networks which serve all 100 North Carolina counties and work for more than 1600 contracted medical homes. CCNC is currently testing ways to integrate community pharmacists into the medical homes system and pioneering new methods of transforming medical practices to pay-for-value forms of provider reimbursement. In 2016, CCNC won the inaugural Hearst Health Award for excellence in improving population health. About Lantana Lantana Consulting Group is a leader in healthcare interoperability, strategy, and standards-based implementation. Lantana’s mission is to make health information available across the spectrum of care, supporting safe, effective, affordable healthcare that improves well-being, public health, quality of care, and research. (http://www.lantanagroup.com) About Computer-Rx Computer-Rx (http://www.winrx.net) provides proven Pharmacy Management Software and Services that promote growth and efficiency in community pharmacy. We combine intuitive software features and the latest technology with a company culture that emphasizes customer service to partner with community pharmacies all over the U.S. to improve patient health. About PioneerRx Developed with the experience of over 35 years of pharmacy software development and support, PioneerRx was built from scratch to provide the pharmacy community with a solution that can grow as the industry changes for the next 35 years. PioneerRx delivers weekly improvements and cutting edge features that are designed to provide speed, simplicity, consistency, and flexibility; however, their goal of development is to help pharmacies make more money. PioneerRx leads the industry in first-to-market functionality in one seamlessly integrated package; they have become one of the most successful and frequently talked about pharmacy systems in the United States. About QS/1 QS/1 offers industry-leading healthcare software solutions to effectively manage independent, chain, hospital outpatient and long-term care pharmacies and HME businesses. QS/1’s complete software solutions are flexible and scalable, making them a valuable and affordable productivity tool for pharmacies – large or small. QS/1 is a division of the J M Smith Corporation, one of the largest privately-held companies in South Carolina. For additional information about QS/1 and the products and services it provides, visit http://www.qs1.com or call 800.231.7776. About Rx30 Rx30 is a total Pharmacy Management Software application that truly acts as the hub for all pharmacy management activities, including prescription dispensing, fully automated refills and reminders, workflow management, medication therapy management and STAR ratings management. The Rx30 platform also excels at adherence management, medication synchronization, document management, smart phone/web refills, e-prescribing, POS, outbound customer communication, IVR integration, business reporting, label printing and a myriad of value added processes and interfaces that assist in streamlining pharmacy management activities and driving profit. For more information, please visit http://www.rx30.com. About VIP Pharmacy Systems: With over 30 years of serving independent pharmacies, VIP Pharmacy Systems is a leader in pharmacy management software, with a focus on speed, reliability, and quality customer care. The result of these efforts is that VIP provides one of the most comprehensive yet easy-to-use pharmacy management systems available. Email sales(at)vip-pharmacy(dot)com to learn how VIP can help you build a better pharmacy. About Creative Pharmacist Co-founded by a community pharmacist and a technology expert in 2008, Creative Pharmacist, developer of the STRAND® clinical platform, is the U.S. market leader in helping pharmacists launch clinical services within their community. They support community pharmacists across the country in engaging patients with chronic disease, such as diabetes, through STRAND®, a wide-reaching intervention, documentation, and education platform. Their mission is to transform the community pharmacy marketplace by inspiring and empowering pharmacists to engage clinical pharmacy practice to improve both the health of their business and the health of their patients. For more information, please visit: http://www.creativepharmacist.com.


News Article | November 30, 2016
Site: www.prweb.com

Mirixa Corporation, the leading provider of medication-related services to health plans and PBMs, announced that Inland Empire Health Plan (IEHP) has selected Mirixa Corporation and the MirixaPro platform to administer medication therapy management services for the IEHP Pharmacy Home Program. The IEHP Pharmacy Home program is one of the first large-scale pharmacy Pay-for-Performance (P4P) programs in the United States. The IEHP Pharmacy Home program teams with local pharmacies to help IEHP members get needed care. This program focuses on care for diabetes, high blood pressure, high cholesterol, and asthma. IEHP-qualified in-network pharmacies help eligible members better manage their medicines. This comprehensive service puts information about members’ medicines and related care in one place. Based on the “medical home” model, the Pharmacy Home program places the member at the center of care. The MirixaPro platform plays a key role in facilitating the IEHP Pharmacy Home program. Mirixa network pharmacies provide ongoing medication therapy management services, including safety alerts, omission and adherence care gaps, and care coordination where high-risk members are followed for a period of time to achieve optimal clinical outcomes. Chris Chan, Pharm D, Senior Director of Pharmaceutical Services at IEHP, explained: “The IEHP Pharmacy Home Program allows us to create clear guidance and infrastructure for its future Community Pharmacy Clinical program including Medication Therapy Management (MTM) which supports our transition to a value-based care model within the IEHP Pharmacy Network. We are pleased to work with Mirixa to set up this innovative outcome-based MTM program. Mirixa’s knowledge in the MTM space, in addition to its software capabilities, will enhance participating pharmacists’ effectiveness to conduct medication reviews.” “We are excited to partner with IEHP in this groundbreaking new program that supports the benefits of pharmacist-delivered services to its Medicare and Medicaid populations,” Frank Harvey, RPh, MBA, CEO at Mirixa, stated. “Mirixa commends IEHP’s desire to enhance the services and capabilities that pharmacies offer to our most vulnerable populations.” About IEHP IEHP, Inland Empire Health Plan, is a not-for-profit Medi-Cal and Medicare health plan located in Rancho Cucamonga, California. With a network of over 4,000 providers and more than 1,800 employees, IEHP serves more than 1.2 million residents in Riverside and San Bernardino counties who are enrolled in Medi-Cal and Cal MediConnect Plan (Medicare). Through a dynamic partnership with providers, award-winning service and innovative products, IEHP is fully committed to providing members with quality, accessible and wellness based healthcare services. http://www.iehp.org. About Mirixa Mirixa Corporation is a leading healthcare technology and services company. We identify and connect patients with trusted pharmacists and other healthcare providers for individualized medication counseling. Our innovative technology and services improve patients' health and reduce costs. For more information, please visit http://www.Mirixa.com.


News Article | November 14, 2016
Site: www.prweb.com

The U.S. Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology (ONC) awarded Lantana Consulting Group a High Impact Pilot (HIP) cooperative agreement to test and refine a standard for pharmacist care plans and to deploy the standard across the Community Pharmacy Enhanced Services Network (CPESN), a project of Community Care of North Carolina (CCNC). The CPESN network provides targeted services to more than three million Medicaid, Medicare, and Dual recipients; and over half will be covered under the participating pharmacy management vendors, PioneerRx and QS/1. “We are excited to support these innovative projects that advance the use of common standards to improve care, particularly in the categories of comprehensive medication management, laboratory data exchange, and care coordination,” said B. Vindell Washington, M.D., M.H.C.M., National Coordinator for health information technology (HHS.gov). “These programs will serve as key building blocks for improving the patient and provider experience with the flow of health information.” Lantana will support CCNC and the vendors as they implement the Pharmacy Care Plan Standard, which will be based on the generic Care Plan recommended in the ONC Interoperability Standards Advisory. Pharmacists will use upgraded pharmacy management systems to submit care plans to improve care coordination. CCNC will receive the care plans and use the EHR-ready, standardized data to assess quality of care. The move to an interoperable care plan will reduce redundant data entry, introduce consistency into the structure and coding of the care plans, and allow clinical information emanating from community pharmacies to be more easily exchanged with other members of the care team. “This project requires that we hit the ground running,” said Zabrina Gonzaga, RN, Manager of Clinical Analysis and Policy. “We know how to deploy standards-based solutions that advance the flow of data through the networks. We are excited to show how this will enhance patient engagement, medication reconciliation, and integration of pharmacy in care coordination.” The ONC award requires that the pilot assess the impact in three areas: practice efficiency, to be measured by change in the volume of care plans relative to a control group; clinical quality, based on number of quality indicators that can be measured via the new data; and interoperability, based on level of plans that pass validation against the new standard. Troy Trygstad, VP of Pharmacy Programs for CCNC, reports “we are thrilled that this award can help us accelerate Community-Based Pharmacy care coordination efforts by integrating their activities with the rest of the care team. As an organization focused on providing wrap around supports for primary care, we see high demand for efficient and effective exchange of care plans and associated information between pharmacies and practices. This will greatly aid in that effort.” CCNC, under a separate initiative, will expand the implementation of the Pharmacist Care Plan to additional pharmacy system vendors, VIP, RX30, ComputerRx, and Creative Pharmacist as part of the CPESN effort. Lantana is one of four organizations awarded a one-year HIP cooperative agreement totaling $1.25 million. ONC awarded the projects based on several factors, including the organizations’ ability to address health IT challenges, scalability, potential impact, technical approach, innovation, and creativity. Each organization’s goals were assessed for alignment with goals of the Department to unlock health data and improve the health of Americans. Lantana Consulting Group is a leader in healthcare interoperability strategy and standards development. Lantana makes health information available across the spectrum of care, supporting safe, effective, affordable healthcare that improves well-being, public health, quality of care, and research. CCNC’s family of companies includes parent company CCNC, Inc. and its wholly owned subsidiary, North Carolina Community Care Networks, Inc., which is a community-based, public-private partnership that creates patient-centered “medical homes” in all 100 counties for North Carolina Medicaid recipients. The CCNC family of companies is dedicated to innovative approaches to population management that improve health and reduce costs, particularly for vulnerable populations. To learn how CCNC improves quality and saves millions of dollars every year, visit http://www.communitycarenc.org. ONC is the principal federal entity charged with coordination of nationwide efforts to implement and use the most advanced health information technology and the electronic exchange of health information. The position of National Coordinator was created in 2004, through an Executive Order, and legislatively mandated in the Health Information Technology for Economic and Clinical Health Act (HITECH Act) of 2009.

Loading Community Pharmacy collaborators
Loading Community Pharmacy collaborators